Cart
sales@molnova.com
Axitinib
CAS No. 319460-85-0
Axitinib( AG-013736 )
Catalog No. M14039 CAS No. 319460-85-0
Axitinib is an oral, potent, and selective inhibitor of vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 30 | In Stock |
|
| 50MG | 41 | In Stock |
|
| 100MG | 55 | In Stock |
|
| 200MG | 69 | In Stock |
|
| 500MG | 135 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAxitinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionAxitinib is an oral, potent, and selective inhibitor of vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3.
-
DescriptionAxitinib is an oral, potent, and selective inhibitor of vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3.
-
In Vitro——
-
In Vivo——
-
SynonymsAG-013736
-
PathwayAngiogenesis
-
TargetPDGFR
-
RecptorPDGFRβ| VEGFR1/FLT1| VEGFR2/Flk1| VEGFR2/KDR| VEGFR3
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number319460-85-0
-
Formula Weight386.47
-
Molecular FormulaC22H18N4OS
-
Purity>98% (HPLC)
-
SolubilityDMSO: 35 mg/mL warmed (90.56 mM)
-
SMILESO=C(NC)C1=CC=CC=C1SC2=CC3=C(C=C2)C(/C=C/C4=NC=CC=C4)=NN3
-
Chemical Name(E)-N-methyl-2-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hu-Lowe DD, et al. Clin Y Res, 2008, 14(22), 7272-7283.
molnova catalog
related products
-
Rinucumab
Rinucumab (REGN 2176) is an anti-platelet-derived growth factor (PDGF) IgG4-like monoclonal antibody that acts by binding to the PDGF-β receptor and can be used to study age-related macular degeneration.
-
Toceranib
Toceranib phosphate is an orally active inhibitor of tyrosine kinase (RTK) receptor, and it potently inhibits PDGFR, VEGFR, and Kit(with Kis of 5 and 6 nM for PDGFRβ and Flk-1/KDR, respectively), has antitumor and antiangiogenic activity.
-
Axitinib
Axitinib is an oral, potent, and selective inhibitor of vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3.
